Anatomic and Functional Outcome of Triamcinolone-assisted 23-gauge Vitrectomy in Vitreomacular Traction Syndrome

作者：Toklu Yasin; Demirel Sibel^*; Sarac Ozge; Cakmak Hasan Basri; Cagil Nurullah

来源：Seminars in Ophthalmology, 2012, 27(3-4): 73-77.

DOI：10.3109/08820538.2012.680640

• 23-gauge vitrectomy
• Triamcinolone acetonid
• Vitreomacular traction

Purpose: To evaluate the outcomes of patients with vitreomacular traction syndrome (VMT) treated with triamcinolone acetonid (TA) assisted 23-gauge (23-G) transconjunctival sutureless vitrectomy.
Methods: Restrospective, case series. The medical charts of 13 eyes of 13 consecutive patients with VMT who underwent 23-gauge transconjunctival pars plana vitrectomy were reviewed. All patients had at least six-month follow-up. The main outcome parameters were changes in best corrected visual acuity (BCVA) and central macular thickness (CMT) between the baseline and postoperative follow-up examinations performed at the first, third, and sixth months after the surgery.
Results: The mean follow-up period was 7 (range 6-15) months. The mean preoperative BCVA was 1.3+/-0.4 (logmar). The final BCVA was 0.5+/-0.3 (logmar) (p = 0.001). The mean CMT was 429+/-85 mu m at baseline, which was significantly reduced to 255+/-47 mu m at the final follow-up visit (p = 0.001). The mean CMT reduction was 174+/-101 (range: 32-348) mu m. No postoperative complications were seen such as endophthalmitis, retinal detachment, hypotony, or glaucoma.
Conclusion: Triamcinolone assisted 23-G transconjunctival sutureless vitrectomy is an effective and safe surgical technique in the management of VMT syndrome. Further studies with large case series are needed.

• 出版日期2012-7